series-b
Stage
2
Investors
About
Bionaut Labs develops precision micro-technology using remote-controlled microscale robots (Bionauts) to deliver biologics, nucleic acids, or small molecule therapies locally to targeted disease areas in the central nervous system, particularly for patients suffering from severe brain disorders such as malignant gliomas and Dandy-Walker Syndrome.
Explore Bionaut Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.